Haemonetics (HAE) –
-
Form 4 HAEMONETICS CORP For: Apr 15 Filed by: Lingamneni Anila
-
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
-
Haemonetics (HAE) Receives FDA Clearance for HN Cartridge
-
Haemonetics Receives FDA Clearance for New TEGĀ® 6s Global Hemostasis - HN Cartridge
-
Form 8-K HAEMONETICS CORP For: Apr 01
-
Haemonetics Corporation Completes Acquisition of Attune Medical
-
Form 4 HAEMONETICS CORP For: Mar 11 Filed by: Simon, Christopher
-
Form 8-K HAEMONETICS CORP For: Mar 05
-
Haemonetics (HAE) to Acquire Attune Medical
-
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
-
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
-
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
-
Form SC 13G/A HAEMONETICS CORP Filed by: VANGUARD GROUP INC
-
Form SC 13G/A HAEMONETICS CORP Filed by: Neuberger Berman Group LLC
-
Form SC 13G/A HAEMONETICS CORP Filed by: Capital Research Global Investors
-
Haemonetics (HAE) PT Lowered to $88 at Citi
-
Form SC 13G/A HAEMONETICS CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form 10-Q HAEMONETICS CORP For: Dec 30
-
Haemonetics (HAE) Tops Q3 EPS by 10c; raises guidance
-
Form 8-K HAEMONETICS CORP For: Feb 08
-
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
-
Form SC 13G/A HAEMONETICS CORP Filed by: BlackRock Inc.
-
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024
-
Form 8-K HAEMONETICS CORP For: Dec 12
-
Haemonetics Corporation Completes Acquisition of OpSens Inc.
-
Haemonetics (HAE) PT Lowered to $90 at Citi
-
Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Form 4 HAEMONETICS CORP For: Nov 01 Filed by: Galvin Roy
-
Form 10-Q HAEMONETICS CORP For: Sep 30
-
Form 8-K HAEMONETICS CORP For: Nov 02
-
Haemonetics (HAE) Tops Q2 EPS by 10c
-
Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
-
Form 4 HAEMONETICS CORP For: Oct 20 Filed by: Basil Michelle L
-
Form 4 HAEMONETICS CORP For: Oct 20 Filed by: Strong Stewart W
-
Form 8-K/A HAEMONETICS CORP For: Oct 10
-
Form 8-K HAEMONETICS CORP For: Oct 10
-
Haemonetics (HAE) to Acquire OpSens for $253M Cash
-
Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.
-
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023
-
Citi Opens Upside 90-Day Catalyst Watch on Haemonetics (HAE)
-
Form 4 HAEMONETICS CORP For: Sep 15 Filed by: Miller Laurie A.
-
Form 4 HAEMONETICS CORP For: Sep 11 Filed by: Lingamneni Anila
-
Form 4 HAEMONETICS CORP For: Sep 12 Filed by: Strong Stewart W
-
Form 144 HAEMONETICS CORP Filed by: Strong Stewart W
-
Form 144 HAEMONETICS CORP Filed by: Lingamneni Anila
-
Form 4 HAEMONETICS CORP For: Sep 05 Filed by: Dockendorff Charles J
-
Form 144 HAEMONETICS CORP Filed by: Dockendorff Charles J
-
Haemonetics (HAE) Announces European Expansion for VASCADE Vascular Closure System
-
Haemonetics Announces European Expansion for VASCADEĀ® Vascular Closure System
-
Form S-8 HAEMONETICS CORP
Back to HAE Stock Lookup